Luspatercept subcutaneous injection used to treat anemia associated with certain blood disorders
Contains luspatercept 25 mg, an erythroid maturation agent that helps red blood cells mature properly, used to treat anemia in beta-thalassemia and certain myelodysplastic syndromes.
Attributes
Product Content
How to Use:
• Administered only by a doctor or nurse by subcutaneous injection, every 3 weeks.
• Dose is decided by your doctor based on body weight and response.
• Regular blood pressure and blood count monitoring is needed.
• Prescription medicine; take exactly as prescribed and consult your doctor before use.
The link to Reblozyl 25mg (S.C) 1 Vial (Refregirated) has been copied